LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.

    Batsuli, Glaivy / Ito, Jasmine / York, Elizabeth S / Cox, Courtney / Baldwin, Wallace / Gill, Surinder / Lollar, Pete / Meeks, Shannon L

    Frontiers in immunology

    2023  Volume 14, Page(s) 1233356

    Abstract: Introduction: Soluble antigens complexed with immunoglobulin G (IgG) antibodies can induce robust adaptive immune responses : Methods: In this study, we analyzed internalization of FVIII complexed with epitope-mapped FVIII-specific IgG monoclonal ... ...

    Abstract Introduction: Soluble antigens complexed with immunoglobulin G (IgG) antibodies can induce robust adaptive immune responses
    Methods: In this study, we analyzed internalization of FVIII complexed with epitope-mapped FVIII-specific IgG monoclonal antibodies (MAbs) by murine bone marrow-derived dendritic cells (BMDCs)
    Results: FVIII complexed with 2-116 (A1 domain MAb), 2-113 (A3 domain MAb), and I55 (C2 domain MAb) significantly increased FVIII uptake by BMDC but only FVIII/2-116 enhanced antibody titers in FVIII
    Conclusion: These findings suggest that a subset of FVIII-IC modulates the humoral response to FVIII in an epitope-dependent manner, which may provide insight into the antibody response observed in some patients with hemophilia A.
    MeSH term(s) Animals ; Mice ; Factor VIII ; Antigen-Antibody Complex ; Hemophilia A ; Epitopes ; Hemostatics ; Immunoglobulin G
    Chemical Substances Factor VIII (9001-27-8) ; Antigen-Antibody Complex ; Epitopes ; Hemostatics ; Immunoglobulin G
    Language English
    Publishing date 2023-08-31
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1233356
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies.

    Ito, Jasmine / Baldwin, Wallace Hunter / Cox, Courtney / Healey, John F / Parker, Ernest T / Legan, Emily R / Li, Renhao / Gill, Surinder / Batsuli, Glaivy

    Journal of thrombosis and haemostasis : JTH

    2021  Volume 20, Issue 3, Page(s) 574–588

    Abstract: Background: A portion of individuals with hemophilia A develop neutralizing antibodies called inhibitors to glycoprotein factor VIII (FVIII). There are multiple risk factors that contribute to the risk of inhibitor formation. However, knowledge of the ... ...

    Abstract Background: A portion of individuals with hemophilia A develop neutralizing antibodies called inhibitors to glycoprotein factor VIII (FVIII). There are multiple risk factors that contribute to the risk of inhibitor formation. However, knowledge of the role of FVIII asparagine (N)-linked glycosylation in FVIII immunity is limited.
    Objective: To evaluate the effect of site-specific N-linked glycan removal on FVIII biochemical properties, endocytosis by murine bone marrow-derived dendritic cells (BMDCs), and antibody responses.
    Methods: Four recombinant B domain-deleted (BDD) FVIII variants with single-site amino acid substitutions to remove N-linked glycans were produced for experimental assays.
    Results: BDD FVIII-N41G, FVIII-N239A, FVIII-N1810A, and FVIII-N2118A with confirmed removal of N-linked glycans and similar glycosylation profiles to BDD FVIII were produced. There were no differences in thrombin activation or von Willebrand factor binding of FVIII variants compared with BDD FVIII; however, reduced FVIII expression, activity, and specific activity was observed with all variants. BDD FVIII-N41G and FVIII-N1810A had reduced uptake by BMDCs, but there were no differences in antibody development in immunized hemophilia A mice compared with BDD FVIII. Half of a repertoire of 12 domain-specific FVIII MAbs had significantly reduced binding to ≥1 FVIII variant with a 50% decrease in A1 domain MAb 2-116 binding to FVIII-N239A.
    Conclusions: Modifications of FVIII N-linked glycans reduced FVIII endocytosis by BMDCs and binding of domain-specific FVIII MAbs, but did not alter de novo antibody production in hemophilia A mice, suggesting that N-glycans do not significantly contribute to inhibitor formation.
    MeSH term(s) Animals ; Antibodies, Monoclonal ; Factor VIII ; Hemophilia A ; Mice ; Polysaccharides ; von Willebrand Factor/metabolism
    Chemical Substances Antibodies, Monoclonal ; Polysaccharides ; von Willebrand Factor ; Factor VIII (9001-27-8)
    Language English
    Publishing date 2021-12-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.15616
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top